Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis. 2008

Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
Laboratory of Nanobiotechnology, Institute of Genetics and Biochemistry, Federal University of Uberlandia, Uberlandia, Minas Gerais, Brazil. neves.af@gmail.com

OBJECTIVE To develop a semi-quantitative method for prostate cancer diagnosis and to validate this technique in clinical protocols with the use of multiplex RT-PCR assays for five different biomarkers associated with carcinogenesis, including the PCA3 gene. METHODS AR, SRD5A2, KLK2, PSMA, and PCA3 transcripts were analyzed by multiplex RT-PCR assay in 73 prostatic tissue samples from patients with prostate cancer (PCa) and benign hyperplasia (BPH). RESULTS Significant differences were observed between cancerous and hypertrophic tissues in the relative expression of these genes. AR, KLK2, PSMA, and PCA3 genes displayed increased transcriptional levels in the cancer specimens; on the other hand, SRD5A2 mRNA levels were higher in the BPH samples. CONCLUSIONS Our results suggest that the most promising marker for PCa diagnosis was positive PCA3 detection associated with serum PSA levels, which showed 28-fold higher chances for cancer occurrence, with 92% specificity and 94% positive predictive value.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011470 Prostatic Hyperplasia Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both. Adenoma, Prostatic,Benign Prostatic Hyperplasia,Prostatic Adenoma,Prostatic Hyperplasia, Benign,Prostatic Hypertrophy,Prostatic Hypertrophy, Benign,Adenomas, Prostatic,Benign Prostatic Hyperplasias,Benign Prostatic Hypertrophy,Hyperplasia, Benign Prostatic,Hyperplasia, Prostatic,Hyperplasias, Benign Prostatic,Hypertrophies, Prostatic,Hypertrophy, Benign Prostatic,Hypertrophy, Prostatic,Prostatic Adenomas,Prostatic Hyperplasias, Benign,Prostatic Hypertrophies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011944 Receptors, Androgen Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA. Androgen Receptors,5 alpha-Dihydrotestosterone Receptor,Androgen Receptor,Dihydrotestosterone Receptors,Receptor, Testosterone,Receptors, Androgens,Receptors, Dihydrotestosterone,Receptors, Stanolone,Stanolone Receptor,Testosterone Receptor,5 alpha Dihydrotestosterone Receptor,Androgens Receptors,Receptor, 5 alpha-Dihydrotestosterone,Receptor, Androgen,Receptor, Stanolone,Stanolone Receptors,alpha-Dihydrotestosterone Receptor, 5
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
January 1999, Hinyokika kiyo. Acta urologica Japonica,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
April 1998, Cancer research,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
December 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
March 2008, The Keio journal of medicine,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
October 2013, BMC genomics,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
January 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
January 2004, Methods in molecular biology (Clifton, N.J.),
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
October 2001, European journal of clinical investigation,
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
October 1997, Journal of applied physiology (Bethesda, Md. : 1985),
Adriana F Neves, and Thaise G Araújo, and Weruska K F S Biase, and Juliana Meola, and Tânia M Alcântara, and Danielo G Freitas, and Luiz R Goulart
January 2001, Anticancer research,
Copied contents to your clipboard!